PATENT CLAIM ANALYSIS

Application Number: 16117407
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "338000"]

Abstract:
The invention relates to pharmaceutical compositions for direct systemic introduction, are also known as DSI pharmaceutical compositions, for used as human veterinary pharmaceutical compositions. In one embodiment, the invention relates to a pharmaceutical composition for direct system introduction comprising bovine gelatin, mannitol, an optional surfactant, an optional flavorant, and an active pharmaceutical ingredient. A DSI pharmaceutical composition of the invention has a disintegration time of 7 seconds or less in deionized water maintained at 37.0° C.±0.5° C. The invention also relates to a method of delivering an active pharmaceutical ingredient to an animal comprising the step of placing a DSI pharmaceutical composition of the invention into a mucosal cavity of an animal to be treated with the active pharmaceutical ingredient and to the corresponding methods of treatment.

Claim (Index 15):
The method of  claim 1 , wherein peptic ulcer disease is treated or prevented.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.98551
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14398085', '14275031', '13343692', '11356451', '13327028']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7239918174725882
- 35 USC 102 Novelty (BERT): 0.5429062831151915
- Combined Prediction Score: 0.7058832640368486
- Mean Citation Score: 221.458608
- Max Citation Score: 353.67352
- Similarity Product: 178.36031708545207

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test